Similar to This
Manus and AI agents explained: What they can do, who needs them
Manus and AI agents explained: What they can do, who needs them: After Deepseek, Manus is now shaking up the AI ​​scene. But why are AI agents so hyped right ...
businessinsider.de/gruenderszene/technologie/hype-um-ki-agenten-wie-manus-was-koennen-sie-und-braucht-ihr-das/
Google AI Chief Says DeepSeek’s Cost Claims Are ‘Exaggerated’
Google AI Chief Says DeepSeek’s Cost Claims Are ‘Exaggerated’: The notion that China’s DeepSeek spent under $6 million to develop its artificial intelligence ...
bloomberg.com/news/articles/2025-02-10/google-ai-chief-says-deepseek-s-cost-claims-are-exaggerated
Is China's DeepSeek an Nvidia killer or overhyped? 4 things to know
Is China's DeepSeek an Nvidia killer or overhyped? 4 things to know: HONG KONG/TAIPEI -- Chinese companies may have felt a sense of satisfaction as they watched ...
asia.nikkei.com/Business/Technology/Artificial-intelligence/Is-China-s-DeepSeek-an-Nvidia-killer-or-overhyped-4-things-to-know
DeepSeek causes a sensation: What's behind the new Chinese AI chatbot?
DeepSeek causes a sensation: What's behind the new Chinese AI chatbot?: The fact that a start-up from China trained its AI model cheaply triggered a share ...
mittelbayerische.de/nachrichten/wirtschaft/deepseek-sorgt-fuer-furore-was-steckt-hinter-dem-neuen-chinesischen-ki-chatbot-17896114
Tech stocks fall sharply after Chinese AI company announces inexpensive ...
Tech stocks fall sharply after Chinese AI company announces inexpensive large language model
pbs.org/newshour/economy/tech-stocks-fall-sharply-after-chinese-ai-company-announces-inexpensive-large-language-model
DeepSeek's AI claims have shaken the world — but not everyone's convinced
DeepSeek's AI claims have shaken the world — but not everyone's convinced: DeepSeek claims its R1 outperforms OpenAI's latest o1 model despite costing a fraction ...
cnbc.com/2025/01/30/chinas-deepseek-has-some-big-ai-claims-not-all-experts-are-convinced-.html
Nightmare on Wall Street as tech stocks in freefall over Chinese AI ...
Nightmare on Wall Street as tech stocks in freefall over Chinese AI startup DeepSeek
nypost.com/2025/01/27/business/nvidia-shares-fall-12-as-chinese-ai-startup-deepseek-triggers-panic/
DeepSeek pulverizes the most valuable company in the world
DeepSeek pulverizes the most valuable company in the world: Its development is said to have cost only a fraction of the billions invested by technology giants ...
morgenpost.de/wirtschaft/article408176332/deepseek-pulverisiert-wertvollstes-unternehmen-der-welt.html
Did US chip export policy provoke the rise of DeepSeek?
Did US chip export policy provoke the rise of DeepSeek?: Emergence of new platform comes weeks after AI diffusion rule
thenationalnews.com/future/technology/2025/01/28/us-chip-exports-ai-deepseek/
USA experiences Sputnik moment: DeepSeek shocks investors
USA experiences Sputnik moment: DeepSeek shocks investors: The new Chinese AI chatbot DeepSeek causes tech stocks to fall by a trillion US dollars ...
freitag.de/autoren/the-guardian/usa-erleben-sputnik-moment-chinesischer-ki-chatbot-deepseek-schockt-investoren
A chatbot from China shocks Wall Street
A chatbot from China shocks Wall Street: SANTA CLARA/CALIFORNIA. Panicked investors have caused the market value of the chip company Nvidia to collapse by almost ...
nachrichten.at/wirtschaft/boerseschock-wegen-ki-aus-china;art15,4020033
Stock market: Why are tech stocks falling today?
Stock market: Why are tech stocks falling today?: Many tech stocks are falling significantly today, Monday. What is the reason for the price losses?
stuttgarter-nachrichten.de/inhalt.warum-fallen-aktien-heute-mhsd.4b8be6c8-3310-4310-b300-e94f51a401bf.html
South Korean author Han Kang wins Nobel literature prize
South Korean author Han Kang wins Nobel literature prize: Award comes against a backdrop of growing international appreciation of her country’s culture
ft.com/content/340b6cba-acb5-4c61-ae0c-65e559aeb8f3
Key FactsObesity Drug Hype: Risks and Expectations
Oct 10, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: ft.com
  • Concerns arise over a potential bubble in GLP-1 obesity drugs, as Eli Lilly and Novo Nordisk generate high expectations.

  • The market for these drugs could reach $200 billion by 2031, yet both companies face intense competition and impending patent expirations.

  • Future Medicare price negotiations and uncertainties regarding possible side effects could impact market performance.

  • Market participants remain largely optimistic, which may signal risk in volatile markets.